Applications of bionanomaterials in neurodegenerative diseases
Open Access
- 23 April 2025
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 6 (12) , 3785-3804
Abstract
Neurodegenerative diseases (NDs) are mainly characterized by progressive neuronal loss, and pose a significant healthcare burden due to limited treatment options and the inefficacy of drugs at the target site within the brain.Keywords
Funding Information
- Anusandhan National Research Foundation
- Indian Institute of Technology Gandhinagar
- Department of Biotechnology, Ministry of Science and Technology, India
- Gujarat Council on Science and Technology
This publication has 181 references indexed in Scilit:
- Lysosome‐Targeting Protein Degradation Through Endocytosis Pathway Triggered by Polyvalent Nano‐Chimera for AD TherapyAdvanced Materials, 2024
- Nanoparticles‐induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation modelsMedcomm, 2023
- Dendrimers as Powerful Building Blocks in Central Nervous System Disease: Headed for Successful NanomedicineAdvanced Functional Materials, 2017
- Oxytocin modulation of neural circuits for social behaviorDevelopmental Neurobiology, 2016
- Targeted Magnetic Nanoparticles for Remote Magnetothermal Disruption of Amyloid‐β AggregatesAdvanced Healthcare Materials, 2015
- A Review of the Potential Role of Nano-Enabled Drug Delivery Technologies in Amyotrophic Lateral Sclerosis: Lessons Learned from Other Neurodegenerative DisordersJournal of Pharmaceutical Sciences, 2015
- A dual magnetic resonance imaging/fluorescent contrast agent for Cathepsin‐D detectionContrast Media & Molecular Imaging, 2012
- Mesoporous Silica Nanoparticle‐based H2O2 Responsive Controlled‐Release System Used for Alzheimer's Disease TreatmentAdvanced Healthcare Materials, 2012
- Micelle‐Based Brain‐Targeted Drug Delivery Enabled by a Nicotine Acetylcholine Receptor LigandAngewandte Chemie International Edition, 2011
- Extended release of a novel antidepressant, venlafaxine, based on anionic polyamidoamine dendrimers and poly(ethylene glycol)‐containing semi‐interpenetrating networksJournal of Biomedical Materials Research Part A, 2004